Sharon benzeno adaptive
WebbSharon Benzeno is a Chief Business Development Officer. Dr. Benzeno has 15 years of biopharmaceutical experience in oncology, therapeutics, R&D and M&A. Prior to joining … WebbDr Sharon Benzeno, Senior Director, Business Development Bioinformatics at Reed Elsevier, considers where the industry goes from here Extracting actionable information …
Sharon benzeno adaptive
Did you know?
WebbDr. Sharon Benzeno is the Chief Commercial Officer, Immune Medicine and leads the Drug Discovery group of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Before joining Adaptive in 2014, Sharon was Senior Director ... WebbSharon Benzeno is Chief Commercial Officer-Immune Medicine at Adaptive Biotechnologies Corp. In the past Dr. Benzeno was Senior Scientific Manager at AstraZeneca Plc and Senior Manager at Capgemini... Sharon Benzeno is Chief Commercial Officer-Immune Medicine at Adaptive Biotechnologies Corp.
WebbSharon Benzeno, PhD, MBA is the Chief Commercial Officer, Immune Medicine and leads the Drug Discovery group of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Before joining Adaptive in 2014, Dr Benzeno … WebbTrack Chair: Sharon Benzeno, Adaptive Biotechnologies PMWC 2024 Luminary Award Ceremony Honoree: Bruce Levine, University of Pennsylvania Advance and Optimize Cell Therapies in Oncology (PANEL) Chair: Sharon Benzeno, Adaptive Biotechnologies - Ira Mellman, Genenetch - Mark Selby, Walking Fish Therapeutics - Sneha Ramakrishna, …
WebbPublic asset : 221,505 USD Linked companies : Adaptive Biotechnologies Corporation Summary Katey Owen is on the board of The End Fund and Adaptive Biotechnologies Corp. and Director-Neglected Tropical Diseases at Bill & Melinda Gates Foundation Trust. She received a doctorate from Purdue University. Current positions of Katey Owen Webb3 feb. 2024 · Sharon Benzeno, PhD is the Chief Business Development Officer and leads the Drug Discovery group of Adaptive Biotechnologies. Prior to joining Adaptive in 2014, Sharon was Senior Director at Elsevier Inc., a healthcare informatics company. Prior to Elsevier, Sharon co-led the oncology business unit at Capgemini SE, a consulting and …
Webb15 juni 2024 · In an earnings call this May, Adaptive said it expected revenue for 2024 to range from $185 to $195 million. Operating expenses were $101.7 million for the first …
Webb1 feb. 2024 · Using a technique called Multiplexed Identification of T-cell Receptor Antigen specificity (MIRA), we input hundreds of antigens of interest, including tumor-associated antigens, viral antigens and neoantigens, and identify thousands of TCRs to these antigens. c str to hexWebbSharon Benzeno - Adaptive Biotechnologies Corp. Cancer Neoantigen Vaccines Speaker Sharon Benzeno Chief Commercial Officer, Immune Medicine at Adaptive … c++ str to int64Webb12 jan. 2024 · Benzeno S 5, Bonnevier JL 6, Chen JQ 7 ... Adaptive Biotechnologies, 1551 ... , 1 Tierra Buck, 1 Sean Hui, 1 Dan Bedinger, 2 Camille Troup, 2 S. Moses Dennison, 3 Kan Li, 3 Michael D. Alpert, 4 Charles C. Bailey, 4 Sharon Benzeno, 5 Jody L. Bonnevier, 6 Jin-Qiu Chen, 7 Charm Chen, 7 Hyeseon Cho, 8, 9 Peter D. Crompton, 8, 9 Vincent ... c str to int64WebbUno de los miembros del panel de expertos fue Sharon Benzeno, doctora y directora comercial de Medicina Inmunológica de “Adaptive Biotechnologies”, que ofreció información alentadora. Consideró que nuestro enfoque se centraba demasiado en las respuestas de anticuerpos y que en el futuro sería posible identificar marcadores … cstr tostring 違いWebb26 okt. 2024 · Chair: Sharon Benzeno, Adaptive Biotechnologies Biomarkers to Guide Immunotherapy Chair: TBD Additional Emerging Therapeutics track themes focus on COVID Therapeutics on Day 1 The COVID Therapeutics Track (Day 1) SARS-CoV-2 vaccines: different vaccine strategies and robustness to viral evolution c str to longWebbAnd now, Adaptive is ready to evolve and generate opportunities across life sciences research, clinical diagnostics, and drug discovery. Our future holds bold discoveries, … cstr to pfrc strtol function